Medilink

Medilink May 2010

This edition covers presentations made at our Strategic Blood Forum in February 2010

• Blood storage lesion and age of transfused components: implications for recipient safety and blood availability
• Implementation of hepatitis B nucleic acid testing (NAT): change in blood component safety
• Hepatitis B nucleic acid testing: implications for lookback
• Clinical impact of measures to reduce bacterial contamination of blood components in Australia
• TRALI and risk reduction strategies
• Pathogen inactivation of blood components
• Research and development at the Blood Service
• International benchmarking data: Australia in perspective
• Clinical demand drivers for intravenous immunoglobulin
• Residual risk extimates for transfusion-transmitted infections
• Conference diary

Medilink August 2009

In this issue:

• Blood Measures
• Preparation, Use and Storage of Thawed Plasma
• Allogeneic Blood Transfusion and Long-term Survival after Cardiac Surgery
• Improving Lives Through the Power of Humanity
• ISBT Regional Congress , Eastern Mediterranean and Europe, March 21-25, Cairo, Egypt
• Patient Blood Management Guidelines Development
• Updated Residual Risk Estimates for Transfusion-Transmitted Infections
• Non-Viral Serious Risks of Blood Transfusion

Medilink December 2008

In this issue:

• Launch of the National Blood Supply Contingency Plan
• Managing the threat of transfusion-transmitted dengue in Australia
• Transfusion Outcomes Research Collaborative
• The Transfusion Question launched
• vCJD in 2008
• Residual risk estimates for transfusion-transmitted infections
• 2009 is Year of the Blood Donor

Medilink August 2008

In this issue:

• ARCBS Bloodhound data contribute to emergency blood supply planning
• Guidelines for the use of Group O Rh(D) negative red cells
• A new transfusion guide for parents and children
• New CSL packaging
• Residual risk estimates for transfusion-transmitted infections
• What's new on www.transfusion.com.au

Medilink March 2008

In this issue:

• Bacterial screening of platelets - update
• New criteria for the use of IVIg in Australia
• 2006 UK SHOT report
• Latest residual risks for TTIs
• ARCBS Brisbane on the move

In this issue:

• Transfusion reaction reporting to ARCBS
• Unexpected consequences of passive antibody transfer in patients receiving IVIg
• Disaster planning for your blood fridge
• Risk of transfusion delay or avoidance
• Universal blood type becomes a reality

In this issue:

• Red cell antibody screening (Rh(D) antenatal prophylaxis program)
• Fourth case of vCJD infection reported in association with blood transfusion
• Efficacy and safety of Biostate in patients with VWD
• Australian Plasma remains onshore
• HLA workshop 
• Introduction of Monofix 1000IU presentation

In this issue:

• Criteria for IVIg use in Australia 
• Plasma fractionation review
• Electronic Returns Information Capture (ERIC) system launched 
• Supply Tracking Analysis Reporting System (STARS) launch 
• Prothrombinex changes
• Transfusion practice improvement meeting
• Non-clinical blood requests
• CSL packaging review

In this issue:

• Australia now self-sufficient in Rh(D)
• Pre-storage versus post-storage leucodepleted blood components
• After the tsunami: rebuilding the Blood Service in Banda Aceh
• Aseptic meningitis and IVIg therapy
• Emergency Blood Management Plan for Australia
• Plasma Fractionation Review
• ARCBS joins Sydney hospitals on eye treatment
• Course in Transfusion Medicine 2006

In this issue:

• Malaria antibody testing increases red cell stock availability
• Strategic Blood Forum tackles hot issues
• Q&As from transfusion.com.au
• Refrigeration failures and blood wastage
• Blood Component Information 2005
• National Blood Transfusion Committee
• Boosting transfusion education
• Reduced bacterial contamination risk

In this issue:

• Establishing a Standing Offer for overseas-sourced IVIg
• Our website has moved
• A national haemovigilance system in Australia?
• Change in ARCBS donor haemoglobin selection guidelines
• Australia sends tetanus immunoglobulin to Aceh
• NAT testing enhances safety of Australia's blood supply
• Pharmacovigilance: drug safety and plasma products
• Blood bag tender evaluation update